Followers | 123 |
Posts | 16653 |
Boards Moderated | 1 |
Alias Born | 07/21/2006 |
Friday, January 22, 2021 1:37:25 PM
Recent PASG News
- Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
- Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program • GlobeNewswire Inc. • 03/05/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/04/2024 10:22:12 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/04/2024 09:09:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2024 12:15:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:02:23 PM
- Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 03/04/2024 12:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:06:29 PM
- Passage Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/27/2024 12:00:26 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:21:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 12:36:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 12:34:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:21:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:20:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:19:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 12:05:51 PM
- Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities • GlobeNewswire Inc. • 12/20/2023 12:00:00 PM
- Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) • GlobeNewswire Inc. • 11/17/2023 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 12:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 12:00:19 PM
- Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 11/13/2023 12:00:00 PM
- Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference • GlobeNewswire Inc. • 10/30/2023 11:00:00 AM
- Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 10/20/2023 08:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM